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Glu~sylat~ human serum albumin (G-HSA) obtained under incubation with glucose at 37°C for 8 days 
sho&$ a new fluorescence with a maximum at 43Onm, resulting in quenching of the fluorescence of only 
one tryptophan residue on HSA. The quantum yield of new fluorescence is 0.024 at 25°C. The analysis 
of the excitation spectra allowed us to con&de the absence of energy transfer. In G-HSA, non~s~ 
cross-linking hexamer was confkmed by SDS-PAGE. 
~o~e~zy~t~ glucosyiat~o~ Hm serum ~~~ PoiyIysine Fluorescence Energy transfer 
Aggregation 
1. I~GDU~IGN 2. MATPRIALS AND METHODS 
It has been reported that, in diabetic patients or 
in experimental nimals with diabetes, glucose ad- 
ducts of various proteins [l-3] as well as hemo- 
globin f4] and albumin [5] are increased. The reac- 
tion yields a stable ketoamine derivative of pro- 
teins through a Schiff-base between glucose and 
primary amine groups of protein, N-terminus or CF- 
amino of lysine residue. To investigate the patho- 
logical sequelae of this reaction, a characterization 
of changes in the structures and functions of 
glucosylated proteins attracts the researcher’s in- 
terests. Serum albumin exerts a transport function 
for drugs through reversible binding [6]. The 
reduction of binding ability of glucosylated human 
serum albumin (G-HSA), which was obtained 
following the in vitro in~bation with glucose, was 
observed for four kinds of sulfonylureas [7], 
bilirubin and cis-parinaric acid [8]. In this paper, 
we demonstrate he presence of a new fluorescence 
and this cannot be attributed tothe energy transfer 
from tryptophan (Trp) residue. Glucosylated HSA 
is polymerized in the glucosylation process. 
All solutions were prepared with l/15 M phos- 
phate buffer, pH 7.4. HSA (Fujirebio Inc., Tokyo) 
solutions were incubated with glucose (200 mM) at 
37’C for 8 ,days, followed by dialysis and lyophili- 
ration. The adsorbed fraction on the phenylboron- 
ate affiity cohunn was referred to G-HSA, as in 
f7]. The ghreose content of HSA was evaluated at 
443 nm according to the thiobarbituric acid (TBA) 
method [9]. The glucosylated poly-lysine(G-p-Lys) 
was obtained by ~bation of 0.18’0 solutions of 
poly-lysine hydrabromide (average molecular mass 
55 000 Da, Sigma) with glucose (150 mM) for 1,3 
or 5 days, followed by dialysis against he buffer. 
SDS gel electrophoresis was carried out at room 
temperature using 5.0% polyacrylamide and 
Tris-HCl buffer, pH 7.4 [lo]. The 0.1% solutions 
of proteinwere used for spectrum measurement. 
The corrected emission and excited fluorescence 
spectra were obtained at 25°C using a Hitachi 
MPF-4 spectrofluorometer following the correc- 
tion by a rhodamine B quantum counter. The 
quantum yields of the fluorescence of G-HSA and 
G-p-Lys (25, 30, 35 and 40°C) were determined by 
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comparison of the integrated corrected emission 
spectrum of a statldard, quinine sulfate with a 
quantum yiekl of 0.54 in 0.1 N H2SO4 ill], with 
that of G-HSA and G-p-Lys obtained by excitation 
at 348 nm. 
3. RESULTS AND DISCUSSION 
As shown in the UV spectra (fig.la), G-HSA 
and G-p-Lys show pigm~tation at the wavelength 
ranging from 300 to 400 nm. At the same wave- 
length region, only one Trp residue on the HSA 
molecule shows fluorescence mission spectrum 
with the maximum at 340 run by Ex. 290 nm (Ex. 
290 nm or Em. 290 nm indicates that the excitation 
or emission wavelength is 290 nm) (fig,Ib). How- 
ever, this fluorescence was reduced by about a half 
of HSA as a result of giucosylation (fig. 1 b). Au- 
thors in [12] reported that an energy trans{er oc- 
curs between two c~omo~hores within 50 A on a 
molecule if the emission spectrum of the energy 
donor overlaps with the absorption spectrum of 
the energy acceptor, and that the fluorescence of
acceptor increases. Fluorescence nergy transfer 
techniques have given useful information on the 
spatial relationships between active sites [13]. 
Therefore, we considered the possibility that the 
fluorescence nergy of the Trp residue may be 
transferred to the pigment on G-HSA, i.e. a new 
chromophore, resulting in the quenching of Trp 
fluorescence. G-HSA showed a new emission spec- 
trum with the maximum at 430 mn showing a small 
shoulder at 470 nm by Ex. 348 nm which is about 
the emission m~imum of Trp ~uorescen~e (fig. 
lb). This fluorescence increased with incubation 
period, in contrast with the decrease of Trp 
fluorescence (f&3)* When the change of the emis- 
sion spectra of Trp residue (Ex. 290 nm) was noted 
in detail, an isosbestic point at 430 nm was ob- 
served. This fact indicates the presence of a weak 
fluorescence at about 430 nm different from that 
of the Trp residue but dependent on the excitation 
energy at 290 nm. It is useful to investigate he ex- 
citation spectra, in order to estimate whether the 
Trp residue and the new chromophore on G-HSA 
could be assumed as donor and acceptor. For the 
complete fficient energy transfer, the excitation 
spectrum observed at the waveIen~h of emission 
maximum of the acceptor is identical with the sum 
28 
Fig. 1. Absorption spectra (a) and fIuoresceuce spectra 
(corrected), (b,c), of human serum ~b~ins and poty- 
lysines. (a) Absorbance scale of poly-lysines i one-half 
of that of HSAs. (b) The dashed lines with maximum at 
340 nm were obtained while exciting at 290 nm. The 
solid lines with the m~mum at 430 nm were obtained 
witiie excitim at 348 nm. (c) The spectra of poly-iysine 
glucose adduct were obtained while exciting at350 nm. 
The O.l@Io solutions of poly-lysine incubated with 150 
mM gfucose for 1, 3 and 5 days, foliowed by dialysis, 
were used. 
of the excitation spectra of the donor and the ac- 
ceptor [12), In the absence of transfer, the excita- 
tion spectrum observed at the same wavelength is
that of the acceptor itself. The latter criterion ap- 
plies to G-p-Lys. The glucosylation of poly-lysine 
resulted in the fluorescence at the same waveIength 
region as G-HSA, increasing with incubatiun 
periods (fig. 1~). The excitation spectra of G-p-Lys 
showed the maximum at 350 nm with a shoulder at 
285 run and a small band at 245 nm (fig,2c), in- 
dicating the presence of some chromopbores con- 
tributing to fluorescence atabout 420 nm. On the 
other hand, the excitation spectra of G-HSA 
observed at Em. 420 nm showed the maximum at 
348 mn and 285 nm with a shoulder at 245 nm 
(fig.2b), showing a similar prolsortion af the sum 
of the excitation spectrum of the Trp residue of 
HSA (fig. 2a) and that of G-p-Lys (fig,2c), as if an 
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Fig- 2. Excitation spectra {corrected) of human serum 
albumins (a,b) and ghmosylated poly-lysine (c). (a) Gb- 
served at emission wavelength of 340 nm. (b) Observed 
at emission wavelength of 420 nm. (c) Observed atemis- 
sion wavelength of 420 nm. The incubation days are in- 
dicated above the lines. 
efficient energy transfer were present. However, 
the emission band at 285 m appeared more 
strongly in HSA than in G-L-ISA. This fact clearly 
indicates that the emission band at 285 nm does 
not originate in the new chromophore of G-HSA, 
but in the Trp residue. This phenomenon isunder- 
stood by considering that the excitation sp~trum 
of the Trp residue assumed as the donor overlaps 
on the spectrum of the new chr~mophor~ assumed 
as the acceptor, because of the wide emission spec- 
trum of the former and the similar iutensity of 
fluorescence in the Trp residue and the new 
chromophore ven at 420 nm. Therefore, it is con- 
sidered that a smaller decrease in the fluorescence 
of G-EEA at about 285 nm in the excitation spec- 
tra which was observed at Em. 420 run (fig,2b) in 
comparison with that observed at Em. 340 nm 
(fig.2a) is attributed to the presence of a chromo- 
phore with an absorption band at about 285 nm in 
the new chromophore, as clearly shown in the ex- 
citation spectrum of G-p-Lys. The quautum yields 
of G-HSA and G-p-Lys at 25°C are 0.024 and 
0.026, respectively, showing very similar values. 
This may reflect an absence of energy transfer. 
These values are one-third of the quantum yield of 
the Trp residue of HSA [ 131. The quantum yield 
decreased as the temperature was increased (fig.4), 
but the shapes of the emission spectra remained 
unaltered. The change of the fluorescence and the 
~y&osyiation process i  shown in fig.3, The absorb- 
Absorbance!, 443nm, -e-) 
0 
1 
Fluorescence (Arbitrary Units) 
Fig. 3. Glu~sylation and changes in fluorescence. 
Glucosylation was estimated at 443 nm by the TBA 
method. Trp fluorescence (+) was monitored at 340 
nm while exciting at 290 nm. For new chromophore 
fluorescence (-+-), the excitation and emission 
wavelengths were 348 nm and 430 mn, respectively. 
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Fig. 4. The effect of temperature on the quantum yields 
of glucosylated human serum albumin (+) and 
glucosylated poly-lysine (-o-). 
ante at 443 mn increased linearly with incubation 
periods, but it seems that the increase in the fluo- 
rescence at 430 run (Ex. 348 mn) and the quenching 
at 340 run (Ex. 290 nm) appeared behind the in- 
crease in the TBA values. The fluorescence prod- 
ucts may be the intermediates of a complicated 
Maillard reaction. The glucosylation of tendon 
collagen [14] has been reported to precede the ap- 
pearance of fluorescence. 
Maillard reaction has been studied in stored 
foods, though special interests have been taken in 
it in relation to aging and diabetes. Freeze-dried 
ovalbumin aggregated by storage with glucose at 
5O”C, and the content of lysine and a-helix 
decreased in proportion to the degree of aggrega- 
tion [15]. In this experiment under physiological 
conditions, non-disulfide cross-linking was also 
confirmed by SDS-PAGE (fig.5). HSA contained 
monomer and dimer, but in G-HSA larger ag- 
gregates, from monomer to hexamer, were detect- 
ed. Authors in [16] reported a very important fact 
that glucosylated ribonuclease A continued to 
generate its trimer through the reaction between 
glucosylated Lys residue and free Lys residues 
after the removal of free glucose. They suggest that 
a short term increase in blood glucose in vivo may 
also exert a long term physiological impact by 
subsequent cross-linking. Intermolecular cross- 
linking in HSA may be more easily formed than in 







Fig. 5. SDS-PAGE of human serum alb lumin and 
glucosylated human serum albumin. Samples were 
heated for 3 min at 100°C in 1% SDS and 2% 2-mer- 
captoethanol before being placed on the gel. 
ized HSA may be extremely altered. Blue fluores- 
cence and UV spectra obtained by this study are 
very similar to those obtained from cross-linked 
lens crystallin through photooxidation [ 171. The 
relationship between new fluorescence and the ag- 
gregation of G-HSA remains to be investigated. 
The distance between Trp214 on domain II and 
Tyr411 on domain III of HSA as reported in [18] 
is approximately 25 A, and the finding that the 
primary site of the glucosylation of HSA is Lys525 
on domain III [8], suggest he possibility of the 
energy transfer, but spectroscopic analysis allows 
us to conclude the absence of energy transfer of 
Trp residue to the new fluorescence pigment. What 
contributes to Trp quenching may be the inter- or 
intra-molecular cross-linking. 
30 
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